Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market... Show more
The Stochastic Oscillator for LH moved into overbought territory on November 12, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
LH moved below its 50-day moving average on October 27, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for LH crossed bearishly below the 50-day moving average on October 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LH's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on LH as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LH just turned positive on November 12, 2025. Looking at past instances where LH's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LH advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
LH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 230 cases where LH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.535) is normal, around the industry mean (12.372). P/E Ratio (26.104) is within average values for comparable stocks, (132.213). Projected Growth (PEG Ratio) (1.948) is also within normal values, averaging (1.928). Dividend Yield (0.011) settles around the average of (0.017) among similar stocks. P/S Ratio (1.624) is also within normal values, averaging (9.791).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. LH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
a provider of medical testing services
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, LH has been loosely correlated with DGX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if LH jumps, then DGX could also see price increases.